New York 2025-2026 Regular Session

New York Senate Bill S04150

Introduced

2/3/25

Refer

2/3/25

Refer

1/7/26

Caption

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

Latest NY S04150 Activity

View All Events: NY 2025-2026 Regular Session S04150

Companion Bills

NY A00265

Same As Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Previously Filed As

NY A00265

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

NY H2217

Relative to opioid reversal drugs

NY AB2150

Employment: training requirements: opioid overdose reversals.

NY S08569

Requires inpatient facilities to dispense at-risk individuals with opioid reversal drugs upon discharge.

NY SB793

Public Health - Opioid Overdose Reversal Drugs

NY HB572

Public Health - Opioid Overdose Reversal Drugs

NY HB1285

Health - Opioid Overdose Reversal Drugs - Possession, Storage, and Administration Past Expiration Date

NY SB164

Opioid Antagonist Availability & State Board of Health

NY LB195

Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications

NY HB395

Procurement - Purchase of Opioid Overdose Reversal Drugs From Opioid Settlement Parties - Prohibition

Similar Bills

No similar bills found.